AngioDynamics
ANGO
170 hedge funds and large institutions have $941M invested in AngioDynamics in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 67 reducing their positions, and 13 closing their positions.
123% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 13
9% more funds holding
Funds holding: 156 → 170 (+14)
4% more capital invested
Capital invested by funds: $902M → $941M (+$39.3M)
0.46% more ownership
Funds ownership: 93.47% → 93.93% (+0.46%)
22% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 67
55% less call options, than puts
Call options by funds: $242K | Put options by funds: $543K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.6M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$8.18M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$7.53M |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$6.13M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$15.7M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$12.1M |
| 3 |
State Street
Boston,
Massachusetts
|
-$5.94M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.79M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.25M |
ANGO Hedge Fund Activity: Q4 2021 in Review
170 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2021, worth a combined $941M — up 4.4% from $902M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ANGO positions and 13 closed out — a net gain of 16 holders — while 52 added to existing stakes and 67 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $11.6M. The largest seller was Bank of Montreal, cutting an estimated $15.7M.
- 170 institutional investors held AngioDynamics (ANGO) as of Q4 2021, up from 156 in Q3 2021.
- Funds reported $941M of AngioDynamics stock for Q4 2021, up 4.4% quarter-over-quarter.
- 29 funds opened new AngioDynamics positions in Q4 2021 and 13 closed out, a net change of +16 holders.
- The largest AngioDynamics buyer in Q4 2021 was Point72 Asset Management, an estimated $11.6M added.
- The largest AngioDynamics seller in Q4 2021 was Bank of Montreal, an estimated $15.7M sold.
Based on aggregated 13F filings for Q4 2021.